University of California, San Diego
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, San Diego sits in the top decile of US sponsors by registered trial count (#43 of 15,742 sponsors by registered trial count).
University of California, San Diego: 775 sponsored US clinical trials, 143 recruiting.
University of California, San Diego sponsors 775 registered US clinical trials on ClinicalTrials.gov, 143 of them currently recruiting, and 499 completed. 104 of these trials are in Phase 3-4 (later-stage) and 170 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Anorexia Nervosa, with 10 trials.
Top-decile sponsor footprint
University of California, San Diego ranks in the top decile of sponsors by registered trial count (#43 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
499 of 553 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
775 total, page 15 of 16
Drug Treatment Validation of Functional Magnetic Resonance Imaging in Generalized Anxiety Disorder
NCT00662259
PACE-PC: Primary Care Management of Adolescent Obesity
NCT00415974
PharmacofMRI (Functional Magnetic Resonance Imaging) of Anxiolytic Medications (Alprazolam)
NCT00703885
Imaging Outcomes of Cognitive Behavioral Therapy (CBT) for Battered Women With Posttraumatic Stress Disorder
NCT01517672
Physical Activity and Basal Metabolic Rate in Postmenopausal Women
NCT01550536
Paracervical Versus Intracervical Lidocaine
NCT00816751
Effect of Ranolazine on Echocardiographic Indices of Diastolic Dysfunction
NCT00574756
Study of Surgically-Induced Weight Loss on Pelvic Floor Disorders
NCT00884871
Single Incision Laparoscopy
NCT00616616
Minimally Invasive Surgery (MIS) Database for the Purpose of Research
NCT00535990
Theca Cell Function in Women With Polycystic Ovary Syndrome (PCOS)
NCT00747617
Minimally Invasive Surgery: Using Natural Orfices
NCT00530998
Ultrasound Guidance Versus Electrical Stimulation for Perineural Catheter Insertion
NCT00877266
Alcohol Use Disorders (AUDs) and Post-traumatic Stress Disorder (PTSD) Treatment for Victims of Partner Violence
NCT00607412
Evaluating the Occurence of New and Progression of Existing Peripheral Venous Disease in Leg Veins
NCT00508079
Cognitive Benefits of Treating Sleep Apnea in Parkinson's Disease
NCT00492115
mDiet - Ecological Momentary Intervention of Diet Via Mobile Technology
NCT00415870
Impact of a Mailed Educational Reminder on Fecal Occult Blood Testing (FOBT): A Randomized Controlled Trial
NCT00534053
Characteristics of Dendritic Cells Before and After Gastric Banding
NCT00488930
Breast Cancer Trials Education Program
NCT02808598
Effect of Ambulatory Continuous Femoral Nerve Blocks on Readiness-for-Discharge Following Total Knee Replacement
NCT00419276
Clinical Trial of CNS-targeted HAART (CIT2)
NCT00624195
Behavior Change and Maintenance Intervention for HIV+ MSM Methamphetamine Users
NCT00432926
Naturalistic Study, Comparison of Divalproex Extended Release (ER) and Quetiapine for Adults With Acute Mania or Mixed Episodes
NCT00397020
How do Sleeping Pills Affect Pain in the Brain?
NCT00414037
A Novel Catheter Lock Solution for Treatment of Tunneled Hemodialysis Catheter-Associated Bacteremia
NCT00614679
STD Risk Reduction for Heterosexual Methamphetamine Users
NCT00344214
Seamos Activas: Increasing Physical Activity Among Latinas
NCT00724165
Effect of Eszopiclone on Sleep Disturbance and Pain in Cancer
NCT00365261
Dietary Supplements for the Treatment of Angelman Syndrome
NCT00348933
Trial of Quetiapine in Anorexia Nervosa
NCT00518973
Effect of Exercise and Diet on Inflammation in Hypertensive Individuals
NCT00338572
Enhancing Consent for Alzheimer's Research
NCT00453544
PACEPro - Mood Management Pilot
NCT00416221
Effects of Light Treatment During Sleep on Young Men
NCT00796939
A Multicenter Study to Assess the Tolerability of Once Daily Lopinavir/Ritonavir (LPV/r) Liquid Versus Capsules
NCT00281606
Pharmacodynamic (PD) Study of Intranodal Adenovirus-CD154 (Ad-ISF35) in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
NCT00850057
PACE-iDP: An Intervention for Youth at Risk for Diabetes
NCT00412165
Azacitidine and Interferon Alfa in Treating Patients With Metastatic Melanoma
NCT00398450
Effects of Lidocaine Patch on Intradermal Capsaicin Induced Pain and Hyperalgesia
NCT00373893
Using Ultrasonography to Predict Clinical Response to Intraarticular Corticosteroids in Knee Osteoarthritis
NCT00414427
Effect of Increased Light Exposure on Fatigue in Breast Cancer
NCT00478257
Evaluating the Relationship Between Stress, Ethnicity, and Blood Pressure
NCT00783497
Effects of Hands-on-Healing vs. Touch for Fatigued Breast Cancer Survivors
NCT00440089
Combination 5-azacitidine and Gemtuzumab Ozogamicin Therapy for Treatment of Relapsed Acute Myeloid Leukemia (AML)
NCT00766116
Non-invasive Measurement of Microvascular Blood Flow During Mild External Compression of the Leg
NCT01804478
Evaluating the Brain's Response to Natural Versus Artificial Sweetener in Women Who Have Had an Eating Disorder
NCT00517335
Visualization of Cerebral Arteries Using Contrast-Enhanced Transcranial Ultrasound in Stroke Patients
NCT00282841
Research in Autism: Parent Intervention
NCT01258465
Weight Reduction Intervention for Breast Cancer Survivors
NCT00774371
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 80 |
| Phase 2 | 90 |
| Phase 3 | 22 |
| Phase 4 | 82 |
Therapeutic Areas
What is open in the University of California, San Diego pipeline
143 recruiting of 775 indexed (18% open); 499 completed (64%).
Phase mix: 104 late (III/IV) vs 170 early (I/II) (early-phase heavy).
Top condition: Anorexia Nervosa (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, San Diego: open-pipeline peers nationwide
Peers matched on 775 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
University of California, San Diego sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 775 trials (± recruiting share)
- Dana-Farber Cancer Institute · 781 trials · 14% recruiting
- Medical University of South Carolina · 755 trials · 19% recruiting
- University of Chicago · 796 trials · 20% recruiting
- University of Utah · 818 trials · 17% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Neurocrine Biosciences · 18% recruiting · 65 trials
- Thomas Jefferson University · 18% recruiting · 292 trials
- Abramson Cancer Center at Penn Medicine · 18% recruiting · 402 trials
- University of Maryland, Baltimore · 18% recruiting · 560 trials
Related
What to do with this University of California, San Diego page
775 registered trials is a research-attention snapshot, not an endorsement of University of California, San Diego or any single study.
- 143 of University of California, San Diego's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Anorexia Nervosa is the condition University of California, San Diego studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Anorexia Nervosa trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, San Diego pipeline card: 775 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.